التفاصيل البيبلوغرافية
| العنوان: |
Vitamin D supplementation to persistent carriers of MRSA—a randomized and placebo-controlled clinical trial. |
| المؤلفون: |
Björkhem-Bergman, Linda, Missailidis, Catharina, Karlsson-Valik, John, Tammelin, Ann, Ekström, Lena, Bottai, Matteo, Hammar, Ulf, Lindh, Gudrun, Bergman, Peter |
| المصدر: |
European Journal of Clinical Microbiology & Infectious Diseases; Sep2018, Vol. 37 Issue 9, p1735-1744, 10p |
| مصطلحات موضوعية: |
METHICILLIN-resistant staphylococcus aureus, DRUG resistance in bacteria, STAPHYLOCOCCUS aureus infections, VITAMIN D, CLINICAL trials, IMMUNITY |
| مستخلص: |
Methicillin-resistant Staphylococcus aureus (MRSA) is resistant to all beta-lactam antibiotics and can cause severe infections that are difficult to treat. Eradication strategies with conventional antibiotics are not always effective and alternative approaches are warranted. Here, we tested the hypothesis that daily supplementation with vitamin D for 12 months would reduce MRSA carriage rates among a group of persistent carriers. This was a double-blind, placebo-controlled randomized trial with n = 65 persistent MRSA carriers with 25-hydroxy vitamin D3 (25OHD) < 75 nmol/L, who were followed up with bacterial cultures at baseline and every 3 months for 1 year. The primary endpoint was the decline in MRSA positivity during the study period. The study was conducted in two MRSA outpatient clinics at the Karolinska University Hospital, Stockholm, Sweden. In total, n = 65 persistent MRSA carriers were randomized and n = 3 were lost to follow-up. Only patients deficient in vitamin D (< 75 nmol/L) were included. Vitamin D (4000 IU) or placebo/day was administered for 12 months. The decline in MRSA positivity was equal in the vitamin D and placebo group during the study period (OR, 1.00; 95% CI, 0.97-1.03; p = 0.928) and approximately 40% in both groups were MRSA-negative after 12 months. The vitamin D group produced 103 positive cultures out of 318 cultures (32.4%) from nose, throat, and perineum over the study period, whereas the placebo group produced 135/393 positive cultures (34.0%) (Fisher’s exact test, p = 0.94). Vitamin D supplementation did not influence MRSA carriage. Thus, available data does not support vitamin D supplementation to persistent MRSA carriers.Trial registration:www.clinicaltrials.gov; NCT02178488. [ABSTRACT FROM AUTHOR] |
|
Copyright of European Journal of Clinical Microbiology & Infectious Diseases is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
